Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
08/2003
08/28/2003WO2002081687A3 Yeast genes that affect viral replication
08/28/2003WO2002081521A3 Osteoprotegerin in milk
08/28/2003WO2002070006A3 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
08/28/2003WO2002068469A3 Modified thrombopoietin with reduced immunogenicity
08/28/2003WO2002029097A3 Methods relating to polymorphisms in the human gpr10 gene
08/28/2003WO2002007752A3 Red blood cell as vehicle for agent-membrane translocation sequence conjugate
08/28/2003US20030162744 Salmon-origin chondroitin sulfate
08/28/2003US20030162736 Medicament comprising NK4 gene or recombinant NK4 protein
08/28/2003US20030162709 Methods of generating multispecific, multivalent agents from VH and VL domains
08/28/2003US20030162705 Liver extract
08/28/2003US20030162704 Method of treatment of parkison's disease with a protein extractable from mammalian organs
08/28/2003US20030162693 Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
08/28/2003US20030162290 Method for inducing differentiation of embryonic stem cells into functioning cells
08/28/2003US20030162175 NK cell receptor polynucleotides, polypeptides, and antibodies
08/28/2003US20030161890 Administering composition comprising water and/or fat-soluble cytosolic extract of pollen combined with Royal Jelly and vitamin E for treatment of disorders related to hormonal variations during fertile, peri- and post menopausal age
08/28/2003US20030161863 Administering mixtures of nutrients for prophylaxis of muscular, metabolic or respiratory disorders, injuries, inflammation and/or to relieve stress
08/28/2003US20030161820 Prevent infections; antiulcer agents
08/28/2003US20030161819 Genetic engineering; promoters; deactivation of major histocompatibility complex
08/28/2003US20030161818 Cultures, products and methods using stem cells
08/28/2003US20030161817 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
08/28/2003US20030161816 Systems and methods for treating patients with processed lipoaspirate cells
08/28/2003US20030161815 Cell delivery system
08/28/2003US20030161814 Adeno-associated virus-mediated delivery of GDNF to skeletal muscles
08/28/2003US20030161813 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules
08/28/2003CA2476451A1 Hyaluronic acid mediated adenoviral transduction
08/28/2003CA2476376A1 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
08/28/2003CA2475437A1 Methods for producing .gamma..delta. t cells
08/28/2003CA2475310A1 Antimicrobial streptococcus salivarius strain and use thereof for preventing dental caries
08/27/2003EP1338648A1 Pharmaceutically acceptable fixed-dried human blood platelets
08/27/2003EP1338285A1 Plasmagel
08/27/2003EP1338281A1 Method for producing an immunotropic antiviral preparation
08/27/2003EP1337655A2 Retroviral vectors containing internal ribosomal entry sites
08/27/2003EP1337640A2 NOVEL RETINA-SPECIFIC HUMAN PROTEINS C7orf9, C12orf7, MPP4 AND F379
08/27/2003EP1337639A2 Master bone formation transcription factor: compositions and methods of use
08/27/2003EP1337632A2 Differentiated cells suitable for human therapy
08/27/2003EP1337626A2 Bacteriophage composition useful in treating food products to prevent bacterial contamination
08/27/2003EP1337625A2 Stem cells, method for expansion in vitro and use thereof
08/27/2003EP1337558A2 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
08/27/2003EP1337276A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor
08/27/2003EP1337263A1 A composition or rose hip and fish oil for alleviating joint pain and stiffness
08/27/2003EP1337242A2 Gene delivery formulations and methods for treatment of ischemic conditions
08/27/2003EP1337152A2 Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
08/27/2003EP1183047B1 Pharmaceutical preparation
08/27/2003EP1124577B1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS
08/27/2003EP1030697B1 Biodegradable polymer scaffold
08/27/2003EP0833657B1 A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection
08/27/2003EP0832186B1 Replacement therapy for dental caries
08/27/2003EP0821693B1 Novel human cytomegalovirus dna sequences
08/27/2003EP0795008B1 Human hypertrophic chondrocyte cell-lines
08/27/2003EP0750458B1 Terminal complement inhibitor fusion genes and proteins
08/27/2003CN1439056A Herpes viruses for immune modulation
08/27/2003CN1439049A Hepatocyte lineage cells derived from pluripotent stem cells
08/27/2003CN1438892A Low carbony drate compositions, kits thereof, and methods of use
08/27/2003CN1438030A Method for preparing tumor specific transfer factors
08/27/2003CN1437976A Gukang capsule (for bone) and its production process
08/27/2003CN1437958A Medicated food for treating rheumarthritis and preparation method thereof
08/27/2003CN1437957A Method for producing whole silkworm powder milk-containing and ferritin
08/27/2003CN1437956A Five-poison chicken for preventing and treating cancer and preparation method
08/27/2003CN1437955A Use of refined fur-seal oil in medicine for preventing and treating climacteric metancholia and menalgia
08/27/2003CN1437932A Method for preparing natural product super-fine powder and micro-nano grade fine powder and composition thereof
08/27/2003CN1119169C Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof
08/27/2003CN1119165C Health-care drink of nourishing spleen and kidney
08/27/2003CN1119161C Medicine for treating rheumatisms
08/27/2003CN1119157C Cough and asthma relieving and phlegm eliminating capsule and its preparation
08/27/2003CN1119154C Live triple bifidobacteria preparation and preparing method thereof
08/27/2003CN1119145C Liposomal compositions and method of using them
08/27/2003CN1119143C Supermicron pearl talcum powder and its preparation process
08/27/2003CN1119142C Supermicron pearl face cream and its preparation process
08/27/2003CN1119080C Implantable agarose-collagen beads containing cells which produce a diffusible bilogical product, and uses thereof
08/26/2003US6610839 Promoter for telomerase reverse transcriptase
08/26/2003US6610706 Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
08/26/2003US6610542 Human immunodeficiency virus; incubating umbilical cord blood cells in a growth medium containing mezerin and concanavalin A; culturing while maintaining reduced levels of the virus; gene expression inhibition
08/26/2003US6610541 Recombinant, active caspases and uses thereof
08/26/2003US6610540 Low oxygen culturing of central nervous system progenitor cells
08/26/2003US6610538 Selecting limbar stem cells capable of regenerating corneal tissue in vitro, preparing a fibrin substrate able to allow limbar cells to grow for production of laminae of epithelium corneae; preparing limbar cornea cell cultures in vitro
08/26/2003US6610535 Progenitor cells and methods and uses related thereto
08/26/2003US6610534 Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases
08/26/2003US6610529 Recombinant bacterial system with environmentally limited viability
08/26/2003US6610526 Human E1-like protein
08/26/2003US6610501 Porcine protein and uses thereof
08/26/2003US6610473 Peptides for inhibiting HPV E6-proteins
08/26/2003US6610334 Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins
08/26/2003US6610294 Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 binds
08/26/2003US6610288 Isolated populations of such hepatocytes and methods for using the hepatocytes to treat subjects with disorders characterized by insufficient liver function are described. The porcine hepatocytes can be either hepatocytes isolated
08/25/2003CA2405347A1 Medicament comprising nk4 gene or recombinant nk4 protein
08/21/2003WO2003068961A2 Method to modify differentiation of pluripotential stem cells
08/21/2003WO2003068954A2 Microorganism for genetic therapeutic treatment of proliferative diseases
08/21/2003WO2003068952A1 Stat3 activated stem cell
08/21/2003WO2003068937A2 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
08/21/2003WO2003068819A1 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
08/21/2003WO2003068809A2 An herpes simplex virus complex
08/21/2003WO2003068800A2 Isolated peptides which bind to hla molecules and uses thereof
08/21/2003WO2003068797A1 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules
08/21/2003WO2003068357A2 Identification and high-yield isolation of human pancreatic islet progenitor and stem cells
08/21/2003WO2003068287A1 Compositions comprising undifferentiated fetal cells for the treatment of skin disorders
08/21/2003WO2003068267A1 Composition for oral or rectal administration
08/21/2003WO2003068250A1 Compositions and methods for treatment of skin disorders
08/21/2003WO2003068249A1 Shark cartilage extracts and use thereof for immunomodulation
08/21/2003WO2003068248A1 Cell delivery system
08/21/2003WO2003068172A2 Undesignated allogeneic stem cell bank